In human endometrium, cell proliferation is regulated by ovarian steroids through heterotypic interactions between stromal and epithelial cells populating this tissue. The authors test the proliferative effects of tibolone and its metabolites using endometrial co-cultures that mimic the normal proliferative response to hormones. They found that both the Delta(4)-tibolone metabolite and the pure progestin ORG2058 counteract estradiol-driven epithelial cell proliferation. Surprisingly, the estrogen receptor binding 3-hydroxyl-metabolites of tibolone also counteracted estradiol-driven proliferation. Inhibition of proliferation by 3beta-OH-tibolone was abrogated by low doses of the progesterone receptor antagonist mifepristone. This suggests that 3beta-OH-tibolone is converted to a progestagenic metabolite. The authors found that the stromal cells used in the co-cultures express high levels of the ketosteroid dehydrogenase AKR1C2, which is able to oxidize 3beta-OH-tibolone back to tibolone. Thus, the unexpected progestagenic effect of 3beta-OH-tibolone in these co-cultures may be due to metabolic activity present in the stromal cells of the co-cultures.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874819PMC
http://dx.doi.org/10.1177/19337191073097198DOI Listing

Publication Analysis

Top Keywords

effects tibolone
8
tibolone metabolites
8
cell proliferation
8
stromal cells
8
cells co-cultures
8
metabolites human
4
human endometrial
4
endometrial cell
4
cell lines
4
lines co-culture
4

Similar Publications

Objective: To assess the effect of contemporary menopausal hormone therapy on the risk of cardiovascular disease according to the route of administration and combination of hormones.

Design: Nationwide register based emulated target trial.

Setting: Swedish national registries.

View Article and Find Full Text PDF

Menopause and endometriosis.

Maturitas

December 2024

Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Viale Golgi 19, 27100 Pavia, Italy; Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS S. Matteo Foundation, Viale Golgi 19, 27100 Pavia, Italy. Electronic address:

Article Synopsis
  • There is growing recognition that endometriosis can affect postmenopausal women, but there is still limited information available on its prevalence and clinical management in this demographic.
  • Symptoms of endometriosis in menopausal patients can be vague and may appear at any stage, making accurate diagnosis challenging.
  • Surgical excision remains the main treatment for symptomatic postmenopausal endometriosis, though there's ongoing debate about the use of hormone therapy due to potential risks, highlighting the need for more research in this area.
View Article and Find Full Text PDF

Effect of Chronic Tibolone Administration on Memory and Choline Acetyltransferase and Tryptophan Hydroxylase Content in Aging Mice.

Brain Sci

September 2024

Unidad de Investigación Médica en Farmacología, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Av. Cuauhtémoc 330, Mexico City C.P. 06720, Mexico.

Gonadal steroids exert different effects on the central nervous system (CNS), such as preserving neuronal function and promoting neuronal survival. Estradiol, progesterone, and testosterone reduce neuronal loss in the CNS in animal models of neurodegeneration. However, hormone replacement therapy has been associated with higher rates of endometrial, prostate, and breast cancer.

View Article and Find Full Text PDF

Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder.

Am J Psychiatry

October 2024

Department of Psychiatry, University Medical Center Groningen, Groningen, the Netherlands (Brand, Sommer, Gangadin); Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland (Tanskanen, Tiihonen, Taipale); Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden (Tanskanen, Tiihonen, Taipale); Center for Psychiatry Research, Stockholm City Council, Stockholm, Sweden (Tanskanen, Tiihonen, Taipale).

Article Synopsis
  • The study examines the impact of menopausal hormone therapy (MHT) on preventing psychosis relapse in women aged 40-62 with schizophrenia or schizoaffective disorder (SSD).
  • Results indicated that MHT use led to a 16% reduction in relapse risk, particularly for women aged 40-55.
  • The findings highlight the potential of MHT as a beneficial treatment option for preventing psychosis relapse in menopausal women, suggesting that current antipsychotic treatments may not be enough for this group.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!